Astec Lifescienc Q2 FY27 Results (NSE: ASTEC)
Signal: Loss narrowed
The read
The trajectory remains a fragile recovery rather than a clean turnaround: consolidated operating margin improved versus the year-ago quarter but fell to -9.06% from approximately -0.80% QoQ, revenue declined 2.3% YoY and 13.8% QoQ, and the loss widened sequentially to ₹2,445.09 lakh. Positive H1 operating cash flow of ₹12,195.71 lakh was driven primarily by working-capital release, not earnings.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹72.02 Cr | -2.3% | -13.8% |
| EBIT | ₹-5.58 Cr | loss increased materially | |
| Net profit | ₹-24.45 Cr | loss reduced 57.5% | |
| EPS | -11.39 | loss per share reduced 59.3% | |
| EBIT margin | -9.06% |
P&L walk
Consolidated revenue declined 2.3% YoY and 13.8% QoQ to ₹7,202.01 lakh; operating margin was -9.06%, sharply below the prior quarter, while the ₹2,445.09 lakh loss was still materially better than the year-ago loss.
Segments
The group reports only one segment, Agrochemicals; the key divergence is between the ₹2,445.09 lakh consolidated loss and the ₹3,739.71 lakh standalone loss, implying subsidiaries or group entities reduced the consolidated drag by ₹1,294.62 lakh.
Key positives
- Consolidated loss reduced 57.5% YoY to ₹2,445.09 lakh, extending the year-on-year recovery in reported profitability.
- Finance costs fell 56.8% YoY to ₹840.86 lakh, providing meaningful support to the bottom line.
- H1 operating cash flow turned positive at ₹12,195.71 lakh versus an outflow of ₹1,995.18 lakh in H1FY26, although the improvement was working-capital-led.
- Consolidated operating margin has improved year on year for the sixth consecutive quarter according to the prior-results series, even though it remains negative.
Key concerns
- Revenue declined 13.8% QoQ to ₹7,202.01 lakh and operating margin fell to -9.06% from approximately -0.80% in the preceding quarter.
- The consolidated loss widened 43.5% sequentially to ₹2,445.09 lakh, showing that the recovery remains uneven.
- Standalone loss of ₹3,739.71 lakh was ₹1,294.62 lakh worse than the consolidated loss, indicating significant parent-level weakness.
- Operating cash flow benefited from a ₹13,183.65 lakh reduction in trade receivables and therefore does not yet demonstrate earnings-backed cash conversion.
Research and educational content only. Not investment advice.